Study to Validate the Questionnaire Called IDSIQ™ in Patients With Insomnia Disorder
NCT03056053
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
113
Enrollment
INDUSTRY
Sponsor class
Conditions
Insomnia Disorder
Interventions
DRUG:
Zolpidem
Sponsor
Idorsia Pharmaceuticals Ltd.